14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of XTLB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for XTL Biopharmaceuticals Ltd.
(Updated on Apr 23, 2024)

Buy or Hold candidate since Mar 27, 2024 Loss -4.07% PDF

The XTL Biopharmaceuticals Ltd. stock price fell by -2.26% on the last day (Tuesday, 23rd Apr 2024) from $2.65 to $2.59. During the last trading day the stock fluctuated 4.78% from a day low at $2.51 to a day high of $2.63. The price has fallen in 7 of the last 10 days and is down by -18.55% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -20 thousand shares and in total, 8 thousand shares were bought and sold for approximately $19.58 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 201.82% during the next 3 months and, with a 90% probability hold a price between $5.98 and $11.84 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

XTLB Signals & Forecast

The XTL Biopharmaceuticals Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.55 and $2.20. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, April 03, 2024, and so far it has fallen -22.22%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for XTL Biopharmaceuticals Ltd. stock

XTL Biopharmaceuticals Ltd. finds support from accumulated volume at $2.47 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.120 between high and low, or 4.78%. For the last week the stock has had daily average volatility of 7.09%.

Our recommended stop-loss: $2.42 (-6.44%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 14 days ago.)

Trading Expectations (XTLB) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect XTL Biopharmaceuticals Ltd. to open at $2.58, and during the day (based on 14 day Average True Range), to move between $2.29 and $2.89, which gives a possible trading interval of +/-$0.297 (+/-11.47%) up or down from last closing price. If XTL Biopharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 22.94% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.62 (1.16%) than the support at $2.47 (4.63%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is XTL Biopharmaceuticals Ltd. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for XTL Biopharmaceuticals Ltd. stock to perform well in the short-term.

Current score: 2.649 Buy Candidate Unchanged

Predicted Opening Price for XTL Biopharmaceuticals Ltd. of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$2.58 ( 0.515%) $2.59

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for XTLB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.70 4.12 %
R2 2.65 2.35 %
R1 2.62 1.26 %
Current price: 2.59
Support S1 2.53 -2.28 %
S2 2.50 -3.38 %
S3 2.46 -5.15 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.07 18.53 %
R2 2.81 8.49 %
R1 2.62 1.16 %
Current price 2.59
Support S1 2.47 -4.63%
S2 2.42 -6.56%
S3 2.38 -8.11%

FAQ

What is the symbol for XTL Biopharmaceuticals Ltd. Stock and on which exchange is it traded?
The symbol for XTL Biopharmaceuticals Ltd. is XTLB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell XTL Biopharmaceuticals Ltd. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for XTL Biopharmaceuticals Ltd. stock to perform well in the short-term.

How to buy XTL Biopharmaceuticals Ltd. Stock?
XTL Biopharmaceuticals Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy XTL Biopharmaceuticals Ltd. Stock.

What's the current price of XTL Biopharmaceuticals Ltd. Stock?
As of the end of day on the Apr 23, 2024, the price of an XTL Biopharmaceuticals Ltd. (XTLB) share was $2.59.

What is the 52-week high and low for XTL Biopharmaceuticals Ltd. Stock?
The 52-week high for XTL Biopharmaceuticals Ltd. Stock is $4.99 and the 52-week low is $0.750.

What is the market capitalization of XTL Biopharmaceuticals Ltd. Stock?
As of the Apr 23, 2024, the market capitalization of XTL Biopharmaceuticals Ltd. is 14.44M.

When is the next earnings date for XTL Biopharmaceuticals Ltd.?
The upcoming earnings date for XTL Biopharmaceuticals Ltd. is May 21, 2024.
Click to get the best stock tips daily for free!

About XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd. XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCD... XTLB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT